Reactive oxygen species (ROS) have been implicated in a growing number of neurological disease states, from acute traumatic injury to neurodegenerative conditions such as Alzheimer’s disease. Considerable evidence suggests that ROS also mediate ototoxicant- and noise-induced cochlear injury, although most of this evidence is indirect. To obtain real-time assessment of noise-induced cochlear ROS production in vivo, we adapted a technique which uses the oxidation of salicylate to 2,3-dihydroxybenzoic acid as a probe for the generation of hydroxyl radical. In a companion paper we described the development and characterization of this method in cochlear ischemia-reperfusion. In the present paper we use this method to demonstrate early elevations in ROS production following acute noise exposure. C57BL/6J mice were exposed for 1 h to intense broad-band noise sufficient to cause permanent threshold shift (PTS), as verified by auditory brainstem responses. Comparison of noise-exposed animals with unexposed controls indicated that ROS levels increase nearly 4-fold in the period 1–2 h following exposure and do not decline over that time. Our ROS measures extend previous results indicating that noise-induced PTS is associated with elevated cochlear ROS production and ROS-mediated injury. Persistent cochlear ROS elevation following noise exposure suggests a sustained process of oxidative stress which might be amenable to intervention with chronic antioxidant therapy.

Keywords:
Free radical, C57BL/6J mouse, Hydroxyl radical, Salicylate, Permanent threshold shift
1.
Althaus JS, Andrus PK, Williams CM, Von Voigtlander PF, Cazers AR, Hall ED: The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Mol Chem Neuropathol 1993;20:147–162.
2.
Cao W, Carney JM, Duchon A, Floyd RA, Chevion M: Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett 1988;88:233–238.
3.
Clerici WJ: Effects of superoxide dismutase and U74389G on acute trimethyltin-induced cochlear dysfunction. Toxicol Appl Pharmacol 1996;136:236–242.
4.
Clerici WJ, Hensley K, DiMartino DL, Butterfield DA: Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 1996;98:116–124.
5.
Dugan LL, Choi DW: Excitotoxicity, free radicals and cell membrane changes. Ann Neurol 1994;35:S17–S21.
6.
Erway LC, Shiau Y-W, Davis RR, Kreig EF: Genetics of age-related hearing loss in mice. III. Susceptibility of inbred and F1 hybrid strains to noise-induced hearing loss. Hear Res 1996;93:181–187.
7.
Fechter LD, Liu Y, Pearce TA: Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig. Toxicol Appl Pharmacol 1997;142:47–55.
8.
Floyd RA, Watson JJ, Wong PK: Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys 1984;10:221–235.
9.
Fredelius L, Rask-Andersen H, Johannson B, Urquiza R, Bagger-Sjoback D, Wersall J: Time sequence of degeneration of the organ of Corti after acoustic overstimulation. Acta Otolaryngol 1988;106:81–93.
10.
Garetz SL, Altschuler RA, Schacht J: Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear Res 1994a:77:81–87.
11.
Garetz SL, Rhee DJ, Schacht J: Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear Res 1994b;77:75–80.
12.
Globus MY-T, Busto R, Lin B, Schnippering H, Ginsberg MD: Detection of free radical activity during transient global ischemia and recirculation: Effects of intraischemic brain temperature modulation. J Neurochem 1995;65:1250–1256.
13.
Götz ME, Kunig G, Riederer P, Youdim MBH: Oxidative stress: Free radicals production in neural degeneration. Pharm Ther 1994;63:37–122.
14.
Gutteridge JMC: Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann NY Acad Sci 1994;738:201–213.
15.
Hall ED, Andrus PK, Yonkers PA: Brain hydroxyl radical generation in acute experimental head injury. J Neurochem 1993;60:588–594.
16.
Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609–1623.
17.
Halliwell B, Kaur H, Ingelman-Sundberg M: Hydroxylation of salicylate as an assay for hydroxyl radicals: A cautionary note. Free Radic Biol Med 1991;10:439–441.
18.
Hamernik RP, Patterson JH, Turrentine GA, Ahroon WA: The quantitative relation between sensory cell loss and hearing thresholds. Hear Res 1989;38:199–212.
19.
Harding GW, Baggot PJ, Bohne BA: Height changes in the organ of Corti following noise exposure. Hearing Res 1992;63:26–36.
20.
Hirose K, Hockenbery DM, Rubel EW: Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear Res 1997;104:1–14.
21.
Hu BH, Zheng XY, McFadden S, Henderson D: The protective effects of R-PIA on noise-induced hearing loss. Hear Res 1997;113:198–206.
22.
Jacono AA, Hu B, Kopke RD, Henderson D, Van De Water TR, Steinman HM: Changes in cochlear antioxidant enzyme activity after sound conditioning and noise exposure in the chinchilla. Hear Res 1998;117:31–38.
23.
Johnson KR, Erway LC, Cook SA, Willott JF, Zheng QY: A major gene affecting age-related hearing loss in C57BL/6J mice. Hear Res 1997;114:83–92.
24.
Jucker M, Ingram DK: Murine models of brain aging and age-related neurodegenerative diseases. Behav Brain Res 1997;85:1–25.
25.
Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Spray D, Garcia P, Steinman H, Malgrange B, Ruben RJ, Rybak L, Van De Water TR: Use of organotypic cultures of Corti’s organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 1997;18:559–571.
26.
Li HS: Influence of genotype and age on acute acoustic trauma and recovery in CBA/Ca and C57BL/6J mice. Acta Otolaryngol 1992;112:956–967.
27.
Liu Y, Fechter LD: MK-801 protects against carbon monoxide-induced hearing loss. Toxicol Appl Pharmacol 1995;132:196–202.
28.
Lopez-Gonzalez MA, Lucas M, Delgado F, Diaz P: The production of free oxygen radicals and nitric oxide in the rat cochlea. Neurochem Int 1998;33:55–59.
29.
Miller JM, Dolan DF, Raphael Y, Altschuler RA: Interactive effects of aging with noise induced hearing loss. Scand Audiol 1998;27:53–61.
30.
Ohlemiller KK, Dugan LL: Elevation of reactive oxygen species following ischemia-reperfusion in mouse cochlea observed in vivo. Audiol Neurootol 1999;4:219–226.
31.
Ohlemiller KK, Dugan LL: In vivo measurement of cochlear reactive oxygen species (ROS) in mice: Effects of noise exposure and cochlear ischemia. Abstr 21st Midwinter Res Meet Assoc Res Otolaryngol, St. Petersburg, 1998, vol 21, p 130.
32.
Ohlemiller KK, Hughes RM, Lett JM, Ogilvie JM, Speck JD, Wright JS, Faddis BT: Progression of cochlear and retinal degeneration in the tubby (rd5) mouse. Audiol Neurootol 1997;2:175–185.
33.
Ohlemiller KK, McFadden SL, Ding D-L, Flood DG, Reaume AG, Hoffman EK, Scott RW, Wright JS, Putcha GV, Salvi RJ: Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss. Audiol Neurootol 1999;4:235–244.
34.
Priuska EM, Schacht J: Formation of free radicals by gentamycin and iron and evidence for an iron/gentamycin complex. Biochem Pharmacol 1995;50:1749–1752.
35.
Pujol R, Puel J-L, D’Aldin CG, Eybalin M: Pathophysiology of the glutamate synapses of the cochlea. Acta Otolaryngol 1993;113:330–334.
36.
Quirk WS, Shivapuja BG, Schwimmer CL, Seidman MD: Lipid peroxidation inhibitor attenuates noise-induced temporary threshold shifts. Hear Res 1994;74:217–220.
37.
Ravi R, Somani SM, Rybak LP: Mechanism of cisplatin ototoxicity: Antioxidant system. Pharmacol Toxicol 1995;76:386–394.
38.
Seidman MD, Quirk WS: The protective effects of tirilated mesylate (U74006F) on ischemic and reperfusion-induced cochlear damage. Otolaryngol Head Neck Surg 1991;105:511–516.
39.
Seidman MD, Quirk WS, Nuttall AL, Schweintzer VG: The protective effects of allopurinol and superoxide dismutase-polyethylene glycol on ischemic and reperfusion-induced cochlear damage. Otolaryngol Head Neck Surg 1991;105:457–463.
40.
Seidman MD, Shivapuja BG: The protective effects of allopurinol and superoxide dismutase on noise-induced cochlear damage. Otolaryngol Head Neck Surg 1993;109:1052–1056.
41.
Siesjo BK, Agardh C-D, Bengtsson F: Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989;1:165–211.
42.
Usami S, Hjelle OP, Ottersen OP: Differential cellular distribution of glutathione – an endogenous antioxidant – in the guinea pig inner ear. Brain Res 1996;743:337–340.
43.
Yamane H, Nakai Y, Takayama M, Iguchi H, Nakagawa T, Kojima K: Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Eur Arch Otorhinolaryngol 1995;252:504–508.
44.
Yamasoba T, Harris C, Shoji F, Lee RJ, Nuttall AL, Miller JM: Influence of intense sound exposure on glutathione synthesis in the cochlea. Brain Res 1998a;804:72–78.
45.
Yamasoba T, Nuttall AL, Harris C, Raphael Y, Miller JM: Role of glutathione in protection against noise-induced hearing loss. Hear Res 1998b;784:82–90.
46.
Yao X, Rarey KE: Detection and regulation of Cu/Zn-SOD and Mn-SOD in rat cochlear tissues. Hear Res 1996;96:199–203.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.